Baldo Vincenzo, Floreani Annarosa, Dal Vecchio Luigino, Cristofoletti Marco, Carletti Maristella, Majori Silvia, Di Tommaso Angela, Trivello Renzo
Department of Environmental Medicine and Public Health, Institute of Hygiene, University of Padua, Italy.
Infect Control Hosp Epidemiol. 2002 Jun;23(6):325-7. doi: 10.1086/502059.
This study presents the results of a 5-year surveillance program involving the prospective follow-up of healthcare workers (HCWs) in the Veneto region of Italy exposed to blood-borne viruses.
All HCWs who reported an occupational exposure to blood-borne infection joined the surveillance program. Both HCWs and patients were tested for viral markers (hepatitis B surface antigen [HBsAg], antibody to hepatitis B surface antigen [anti-HBs], antibody to hepatitis B core antigen [anti-HBc], antibody to hepatitis C virus [anti-HCV], HCV RNA, and antibody to human immunodeficiency virus [HIV]) and had these markers plus transaminases assayed at 3, 6, and 12 months and then yearly thereafter. Moreover, a program of hepatitis B virus (HBV) prophylaxis was offered to those whose anti-HBs levels were less than 10 IU/mL.
Two hundred forty-five HCWs (156 women and 89 men) with a mean age of 37 (+/- 10) years who reported occupational exposure during the 5-year period.
At the time of exposure, 1 HCW was positive for HBsAg (0.4%) and 2 were positive for HCV RNA (0.8%). Among the patients involved, 28 (11.4%) were positive for HBsAg, 68 (27.8%) were positive for HCV RNA, 6 (2.4%) were positive for HIV, and 147 (60.0%) were negative for all viral markers (4 patients were positive for both HCV and HIV). During the follow-up period after exposure (mean, 2.7 [+/- 1.6] years), there was no increase in transaminases or seroconversions to any of the viral markers.
Our accurate postexposure follow-up revealed a lack of transmission of HBV, HCV, and HIV.
本研究展示了一项为期5年的监测项目结果,该项目对意大利威尼托地区接触血源性病原体的医护人员进行前瞻性随访。
所有报告职业性接触血源性病原体感染的医护人员均加入该监测项目。医护人员和患者均接受病毒标志物检测(乙肝表面抗原[HBsAg]、乙肝表面抗原抗体[抗-HBs]、乙肝核心抗原抗体[抗-HBc]、丙肝病毒抗体[抗-HCV]、HCV RNA以及人类免疫缺陷病毒抗体[HIV]),并在接触后3个月、6个月和12个月以及之后每年检测这些标志物及转氨酶。此外,为抗-HBs水平低于10 IU/mL的人员提供乙肝病毒(HBV)预防方案。
245名医护人员(156名女性和89名男性),平均年龄3